| ACEs | Adverse childhood experiences |
| ADHD | Attention-deficit/hyperactivity disorder |
| AHR | Aryl hydrocarbon receptor |
| ANS | Autonomic nervous system |
| ASD | Autism spectrum disorder |
| BAs | Bile acids |
| BBB | Blood–brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| CNS | Central nervous system |
| CPE | Cerebral palsy with epilepsy |
| CRF | Corticotropin-releasing factor |
| DG | Dentate gyrus |
| DMN | Default mode network |
| ENS | Enteric nervous system |
| FAS | Fetal alcohol syndrome |
| FASDs | Fetal alcohol spectrum disorders |
| FMT | Fecal microbiota transplantation |
| GABA | Gamma-aminobutyric acid |
| GBA | Gut–brain axis |
| GF | Germ-free |
| GI | Gastrointestinal |
| GM | Gut microbiome |
| GPRs | G-protein coupled receptors |
| HDACs | Histone deacetylases |
| HPA | Hypothalamic–pituitary–adrenal |
| 5-HT | Serotonin |
| KYN | Kynurenine |
| LPS | Lipopolysaccharide |
| miRNAs | microRNAs |
| NDDs | Neurodevelopmental disorders |
| NMDA | N-methyl-D-aspartate |
| PAE | Prenatal alcohol exposure |
| PFC | Prefrontal cortex |
| PRRs | Pattern recognition receptors |
| ROI | Recurrence of illness index |
| RSFC | Resting state functional connectivity |
| SCFAs | Short-chain fatty acids |
| SGZ | Subgranular zone |
| SLs | Sphingolipids |
| SPF | Specific pathogen-free |
| SSRIs | Selective serotonin reuptake inhibitors |
| SVZ | Subventricular zone |
| TDs | Tic disorders |
| TLRs | Toll-like receptors |
| TPH1 | Tryptophan hydroxylase type 1 |
| TPH2 | Tryptophan hydroxylase type 2 |
| TS | Tourette syndrome |